Which is NOT part of a comprehensive medication review?

A comprehensive medication review is a systematic process that focuses on assessing a patient's medications to ensure their effectiveness, safety, and adherence. It typically involves several key components aimed at optimizing therapeutic outcomes.

Identifying errors of omission and checking for errors of commission are both integral to the review process. Errors of omission refer to necessary medications that a patient is not taking, while errors of commission involve medications that should not be prescribed or are inappropriate for a patient’s condition. Both types of errors can significantly impact patient health and are essential to identify during this comprehensive assessment.

Assessing medication adherence is also a crucial part of the medication review, as it involves evaluating whether a patient is taking their medications as prescribed. Non-adherence can lead to complications, hospitalizations, and ineffective treatment regimens, making this evaluation vital to ensure that patients derive the intended benefits from their medications.

Verifying the patient's insurance, while important for practical considerations regarding medication access and affordability, does not directly contribute to understanding the efficacy or appropriateness of the medications themselves. Therefore, it is not considered part of a comprehensive medication review, which is focused on clinical aspects rather than administrative or financial ones.